VKTX
Viking Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.67
+6.06%Leverage
- Debt / equity
- 0.43x
- Net debt / equity
- -0.72x
- Debt / assets
- 0.26x
- Debt / EBITDA
- -0.41x
- Net debt / EBITDA
- 0.67x
Liquidity & coverage
- Current ratio
- 7.27x
- Quick ratio
- 7.27x
- Cash ratio
- 7.17x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $839.1M
Cash & dividend
- FCF / debt
- -1.82x
- Cash flow / debt
- -1.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026